Ypsilon Therapeutics

Private

Houston, TexasHealthcare & Life Scienceshttps://ypsilontx.com/

Last Round

Seed

Nov 20, 2024

Total Funding Raised

$2.73M

Company Overview

Ypsilon Therapeutics is a biotechnology company developing T-cell receptor mimic (TCRm) antibody and bispecific T-cell engager therapies for the treatment of solid tumors.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

biotechnologydrug discoveryprotein engineeringbispecific antibodiesTCR-mimic antibodiesTCRmbiologicsantibody therapeuticsoncologytherapeutic targetspreclinical researchdrug developmentbiotech partneringpharma licensingnext-gen biologics

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Ypsilon Therapeutics Comps

Public and private peers based on sector, stage, and business model.

Ypsilon Therapeutics comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Ypsilon Therapeutics Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Seed	Nov 20, 2024

View all Funding Rounds

Key People

Founding team and executive leadership

Dongxing Zha

Director Board of Directors, Founder and CEO

Founding Team

Ypsilon Therapeutics Investors

Notable investors and investment history

Ypsilon Therapeutics investors
Investor	Rounds
82VS	Seed
Cancer Prevention and Research Institute of Texas	Seed

View all Investors

Ypsilon Therapeutics Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Ypsilon Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Ypsilon Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersHouston, Texas

Employee Range3

Year Founded2022

Last FundingNov 20, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.